Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer
Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer
Arimidex Continues To Show Improvement Over Tamoxifen
Iressa May Benefit Some Breast Cancer, Studies Find
Gleevec Improves Survival Of CML In Accelerated Phase
Phase II Study Tests Chemo Plus Mylotarg For AML
“Proof Of Concept” Shown In Early Trial Of PKC-412
Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis
Clinical Trials Approved By NCI During November Are Listed
Trending Stories
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine - An overlooked immune cell population may offer new direction for cell and gene therapy
- Understanding the impact of the Israeli-U.S. attacks on Iran’s nuclear facilities
- Rick and Mary Pazdur on facing “the other side of the stethoscope”
A few months before Mary died of ovarian cancer, the couple shared how this experience shaped their perspectives on oncology
